Resveratrol does not benefit patients with nonalcoholic fatty liver disease.
Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ.
Chachay VS, et al. Among authors: macdonald ga.
Clin Gastroenterol Hepatol. 2014 Dec;12(12):2092-103.e1-6. doi: 10.1016/j.cgh.2014.02.024. Epub 2014 Feb 25.
Clin Gastroenterol Hepatol. 2014.
PMID: 24582567
Clinical Trial.